HCEMM-SU Molecular Oncohematology Research Group

Group Leader

Csaba Bödör Phd

Group Leader

PERSONAL INFORMATION

Name: Bödör, Csaba
Nationality: Hungarian

Qualification

  • 2005: MSc degree, molecular biologist, specialization: immunology, Eötvös Loránd University of Natural Sciences, Budapest, Hungary.
  • 2008: PhD degree, Molecular Oncology program, Doctoral School of Pathology, Semmelweis University, Budapest, Hungary.
  • 2020: MSc degree, Healthcare manager, Semmelweis University, Health Services Management Training Centre, Budapest, Hungary
  • 2021: Certified Clinical Biochemist, Semmelweis University, Budapest)

Positions

  • 2021-present Group leader, HCEMM-SU Molecular Oncohematology Research Group, Hungarian Centre of Excellence for Molecular Medicine
  • 2017-present: Head of the Molecular Diagnostics Division, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary
  • 2015-2020: Group leader, MTA-SE Lendulet Molecular Oncohematology Research group of the Hungarian Academy of Sciences, Budapest, Hungary.
  • 2014- present: Senior research fellow and Lead of the molecular diagnostic laboratory section of the Oncohematology Center at the Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • 2013- 2015: Honorary Postdoctoral research fellow at Barts Cancer Institute, Centre for Hemato-Oncology, Barts Cancer Institute, London, UK.
  • 2010- 2013: European Hematology Association (EHA) funded Honorary Postdoctoral research fellow at Barts Cancer Institute, Centre for Hemato-Oncology, Barts and the London School of Medicine and Dentistry, London, UK.
  • 2009- 2010: Lead of the molecular diagnostic laboratory section of the Oncohematology Center at Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • 2005- 2008: Ph.D. student, Department of Pathology and
    Experimental Cancer Research, Semmelweis University, Budapest, Hungary.

Teaching Activities

  • 2013-present: Pathology lectures, Immunology and Genetics seminars in graduate medical training program at Semmelweis University, Budapest, Hungary (in Hungarian and in English).
  • Lectures on molecular oncology/diagnostics in postgraduate PhD program at Semmelweis University, Budapest, Hungary.
  • Visiting seminar leader (biology and chemistry) at Milestone Institute, Budapest, Hungary (English program).
  • 2010-2013: Molecular biology seminars (FunMed) for medical students at Barts Cancer Institute, Centre for Hemato-Oncology, Barts and the London School of Medicine and Dentistry, London, UK
  • 2006- 2010: Biology lecturer (cell biology, molecular biology, genetics); College International, Budapest, Pre-Medical preparatory
    course for medical universities (English program).
  • 2007- 2010: Coordination of MSc projects of undergraduate students in
    the Molecular Diagnostics laboratory, lectures on molecular pathology (Semmelweis University, Budapest),

Routine Diagnostic Activity

  • 2013-present: Head of the molecular diagnostic laboratory of the National Oncohematology Centre at Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest.
  • 2005- 2010: Responsible for the coordination of molecular diagnostic procedures in the Molecular Diagnostics laboratory of the Oncohematology Centre at the Department of Pathology, Semmelweis University, Budapest

Memberships

  • Elected board member of the Hungarian Society of Personalized Medicine (2020)
  • Representative of the Semmelweis University in the Eurolife international consortium (2019)
  • Elected member of the executive board of the Hungarian Society of Hematology and Transfusion (2013) and secretary (2017)
  • Member of the molecular diagnostic board of the EWOG-MDS international group (2017)
  • Founding member of the Molecular Pathology workgroup of the Hungarian Society of Personalized Medicine (2012)
  • European Hematology Association-EHA (2010)

Field of Interest

  • Molecular genomics and pathogenesis of lymphomas
  • Epigenetics
  • Personalized medicine, targeted therapy

Awards

  • 2021, 2019 Merit award (Semmelweis University)
  • 2018 Excellent mentor award in the student research program (Semmelweis University)
  • 2018 Kelemen Endre publication award (Hungarian Society of Hematology and Transfusion)
  • 2016 Best review article (“Magyar Onkológia”: Hungarian Oncology)
  • 2014 Junior Prima Award of the Prima Primissima foundation
  • 2014 Merit Award (Semmelweis University)
  • 2013 Szent-Györgyi Albert post-doctoral scholarship, award of the National Excellence program (12 months)
  • 2010 European Hematology Association (EHA) Partner Fellowship
  • 2006 Award of Richter-Gedeon pharmaceutical company for research activities during the Ph.D. program

Additional Training

  • 2012 Exome sequencing and data analysis course: Imperial College London, January 2012.
  • 2011 Joint EBI-Wellcome Trust Summer school in bioinformatics, Hinxton, Cambridge, UK, 2011.

Independent Grant Funding

  • Epigenetic model of Follicular Lymphoma, European Hematology Assocation (EHA) post-doctoral partner fellowship, 3 years (2010-2012); 105.000 EUR.
  • Aberrant epigenetic regulation in follicular lymphoma, Szent-Györgyi Albert post-doctoral scholarship, 1 year (2013.05-2014-05); 20.000 EUR.
  • Investigation of the genetic background of familial myelodysplastic syndromes (MDS) and acute myeloid leukaemias (AML), OTKA-PD grant, 2 years (2013.09-2015.09); 25.000 EUR
  • Personalised medicine in B-cell lymphomas (MTA Momentum grant of the Hungarian Academy of Sciences) (2015-2020); 300.000 EUR.
  • Liquid biopsy-based identification and monitoring of novel therapeutic targets in B-cell lymphomas. NKFIH-KH17 grant (2018-2019); 65.000 EUR
  • ERA-PERMED Human disease modelling of GATA2-related Myelodysplastic Syndromes and Acute Myeloid Leukemia (2019-2022). 1.000.000 EUR.
  • Liquid biopsy based genomic profiling and minimal residual disease detection in mature B-cell lymphomas. HCEMM Translational Research Group program (2021-2026);

Ad Hoc Manuscript Reviewer Activity

  • Oncotarget, Expert Review of Hematology, Oncogenesis
  • Pathology and Oncology Research, Genes, Cancers

International Grant Reviewer Activity

  • ERA-PerMED international grants

Editorial Board Memberships

  • Journal of Hematology and Transfusion, deputy editor in-chief

Publication Activity

  • Number of scientific publications: 87
  • Cumulative impact factor: 273.512
  • Citations: 1676
  • Hirsch index: 19

Publications in The Following High Impact Journals

  • Nature Genetics, Nature Communications
  • Blood, Leukemia, Haematologica
  • Journal of Clinical Investigation

Contact

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
This website uses cookies. For more information visit the Cookies & Privacy Policy page.
Skip to content